Bristol-Myers Squibb Company

Stock Chart, Company Information, and Scan Results

$54.70(as of Dec 24, 12:33 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bristol-Myers Squibb Company Company Information, Fundamentals, and Technical Indicators

Stock Price$54.70
Ticker SymbolBMY
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees34,100
CountyUSA
Market Cap$111,274.3M
EBIDTA19,217.0M
10-Day Moving Average53.34
P/E Ratio18.32
20-Day Moving Average51.78
Forward P/E Ratio8.96
50-Day Moving Average48.04
Earnings per Share2.97
200-Day Moving Average47.91
Profit Margin18.01%
RSI68.29
Shares Outstanding2,035.8M
ATR1.25
52-Week High61.00
Volume14,780,797
52-Week Low42.38
Most Recent Support Level53.09
Book Value18,600.0M
Most Recent Resistance Level54.86
P/B Ratio5.95
Upper Keltner54.59
P/S Ratio2.30
Lower Keltner48.97
Debt-to-Equity Ratio54.59
Next Earnings Date02/05/2026
Cash Surplus-12,410.0M
Next Ex-Dividend Date01/02/2026

BMY takes the fight against disease to the heart, with leading cardiovascular medications like Camzyos—an FDA-approved treatment for obstructive hypertrophic cardiomyopathy. The global biopharmaceutical company is also well-known for its development of oncology and immunology products, including Opdivo and Yervoy for cancer treatment, and Orencia for rheumatoid arthritis. If you are looking to add a well-diversified biopharmaceutical stock to your portfolio, BMY could be the one.

Bristol-Myers Squibb Company In Our Stock Scanner

As of Dec 24, 2025
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.